United Therapeutics (UTHR) Intangibles (2016 - 2020)
Historic Intangibles for United Therapeutics (UTHR) over the last 10 years, with Q1 2020 value amounting to $128.9 million.
- United Therapeutics' Intangibles fell 639.07% to $128.9 million in Q1 2020 from the same period last year, while for Mar 2020 it was $128.9 million, marking a year-over-year decrease of 639.07%. This contributed to the annual value of $128.9 million for FY2019, which is 639.07% down from last year.
- According to the latest figures from Q1 2020, United Therapeutics' Intangibles is $128.9 million, which was down 639.07% from $128.9 million recorded in Q4 2019.
- United Therapeutics' 5-year Intangibles high stood at $137.7 million for Q3 2018, and its period low was $21.5 million during Q1 2016.
- For the 5-year period, United Therapeutics' Intangibles averaged around $75.2 million, with its median value being $30.4 million (2017).
- In the last 5 years, United Therapeutics' Intangibles surged by 35296.05% in 2018 and then plummeted by 639.07% in 2019.
- United Therapeutics' Intangibles (Quarter) stood at $21.5 million in 2016, then skyrocketed by 41.4% to $30.4 million in 2017, then soared by 352.96% to $137.7 million in 2018, then fell by 6.39% to $128.9 million in 2019, then changed by 0.0% to $128.9 million in 2020.
- Its Intangibles was $128.9 million in Q1 2020, compared to $128.9 million in Q4 2019 and $128.9 million in Q3 2019.